Univest
Univest
  • Markets

DSP Healthcare Fund Analyst Review: NAV, Returns and Key Insights 2026

  • June 4, 2026
  • Posted by: Kashish Aggarwal
  • Category: Mutual Funds
No Comments
DSP Healthcare Fund Analyst Review

The DSP Healthcare Fund Direct Growth plan has returned 10.82% over the past year, reflecting conditions in its investment segment. With a NAV of Rs 45.5 and an AUM of Rs 3,142.36 crore, the fund continues to maintain investor interest. This analyst review covers performance history, expense ratio, associated risks, and investment suitability for 2026.

Click Here – Get Mutual Fund Advisory

Table of Contents

Toggle
  • What Is the DSP Healthcare Fund?
  • DSP Healthcare Fund NAV and AUM
  • DSP Healthcare Fund Returns: Performance Snapshot
  • Expense Ratio and Cost Efficiency
  • Who Should Invest in DSP Healthcare Fund?
  • Key Risks to Consider
  • Conclusion
  • Frequently Asked Questions
    • What is the current NAV of DSP Healthcare Fund?
    • What are the returns of DSP Healthcare Fund?
    • What is the expense ratio of DSP Healthcare Fund Direct Growth?
    • Is this fund suitable for conservative investors?
    • What is the minimum SIP amount for this fund?
    • What category and sub-category does this fund belong to?

What Is the DSP Healthcare Fund?

The DSP Healthcare Fund is a Sectoral/Thematic equity fund concentrating its portfolio around a specific sector, industry, or investment theme. Thematic funds offer high-conviction, focused exposure that can generate outsized returns when the theme performs well but also amplifies drawdowns during adverse cycles. The fund carries a Very High risk rating and is best used as a satellite allocation within a diversified portfolio.

DSP Healthcare Fund NAV and AUM

The current NAV of the DSP Healthcare Fund Direct Growth plan is Rs 45.5. NAV is updated each trading day and reflects the closing market prices of the fund’s underlying securities. Always verify the most recent NAV on the AMC website or a registered mutual fund platform before placing any transaction.

The fund manages Rs 3,142.36 crore in assets, indicating a healthy investor base with meaningful conviction in its investment approach and adequate liquidity for most investor needs. Investors should track AUM trends alongside performance metrics when evaluating this fund.

DSP Healthcare Fund Returns: Performance Snapshot

Period Returns
1 Month 7.62%
3 Months 10.32%
1 Year 10.82%
3 Years (Annualised) 24.85%
5 Years (Annualised) 15.75%

The DSP Healthcare Fund has returned 10.82% over the past year and 10.32% over three months, reflecting softer conditions in its investment segment. Investors evaluating this fund should compare returns against the benchmark and category peers, and ensure they have a sufficient time horizon to absorb any further periods of subdued performance before committing capital.

Expense Ratio and Cost Efficiency

The DSP Healthcare Fund Direct Growth plan carries an expense ratio of 0.52% per annum, a competitive figure for its fund category. A lower expense ratio means a larger proportion of gross returns is retained by the investor. Combined with the direct plan’s elimination of distributor commissions, this provides a strong cost-to-value proposition over a long investment horizon.

Who Should Invest in DSP Healthcare Fund?

The DSP Healthcare Fund suits investors with high conviction in the specific sector or theme the fund targets, combined with a Very High risk appetite and a minimum 5 to 7-year horizon. The minimum SIP is Rs 100 and minimum lumpsum is Rs 100. Thematic funds should be used as satellite allocations of 10 to 15 percent rather than as core holdings. Investors without a specific view on the underlying theme should avoid this fund.

Key Risks to Consider

Concentration Risk: Thematic funds invest in a narrow market segment. A structural or cyclical downturn in the specific sector or theme provides limited diversification away from the adverse impact.

Timing Risk: Entry at peak valuations during a theme’s popularity can result in extended periods of underperformance. Thematic funds are highly sensitive to investor entry and exit timing.

Regulatory Risk: Sectors such as defence, pharma, and energy can be significantly impacted by government policy changes or regulatory shifts that are difficult to predict in advance.

Concentration Risk: Funds with a focused investment mandate are more vulnerable to segment-specific headwinds than broadly diversified equity schemes.

Download the Univest iOS App or Univest Android App to track this fund’s live NAV and manage your portfolio.

Conclusion

The DSP Healthcare Fund has delivered modest returns in a challenging environment, but its expense ratio of 0.52% and AUM of Rs 3,142.36 crore reflect a cost-efficient and investor-supported structure. Those already holding this fund should review the underlying investment thesis. New investors should ensure they have a sufficient horizon before committing capital. Consult a SEBI-registered investment advisor before any allocation change.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions

What is the current NAV of DSP Healthcare Fund?

Ans. The current NAV of the DSP Healthcare Fund Direct Growth plan is Rs 45.5. NAV is updated each trading day and reflects the closing market value of the fund’s underlying holdings. Always verify the most recent NAV on the AMC website or a SEBI-registered mutual fund platform before transacting.

What are the returns of DSP Healthcare Fund?

Ans. The fund has delivered a 1-year return of 10.82% and a 3-month return of 10.32%. The 3-year annualised return is 24.85% and the 5-year annualised return is 15.75%. Past performance does not guarantee future results and should be evaluated alongside the fund’s risk profile and benchmark comparison.

What is the expense ratio of DSP Healthcare Fund Direct Growth?

Ans. The expense ratio of the DSP Healthcare Fund Direct Growth plan is 0.52% per annum. The direct plan eliminates distributor commissions and is more cost-efficient than the regular plan. Investors should always opt for the direct plan to maximise long-term net returns through the compounding advantage of lower costs.

Is this fund suitable for conservative investors?

Ans. No. This fund carries a Very High risk rating due to concentrated exposure to a specific market segment or investment theme. It is not suitable for conservative investors or those with short investment timelines. A minimum 5 to 7-year horizon and a high risk tolerance are required prerequisites. Consult a SEBI-registered investment advisor before investing.

What is the minimum SIP amount for this fund?

Ans. The minimum monthly SIP is Rs 100 and the minimum lumpsum investment is Rs 100. The low entry thresholds make the fund accessible across income levels. A regular SIP approach is recommended to average out entry costs over time, particularly given the high-volatility nature of this fund’s category.

What category and sub-category does this fund belong to?

Ans. This fund is a Sectoral/Thematic equity fund with a focused portfolio aligned to a specific sector or theme. It falls under the Sectoral / Thematic sub-category and is available as a direct growth plan, which eliminates distributor commissions and typically offers superior net returns compared to the regular plan.



Author: Kashish Aggarwal
Kashish Aggarwal is a Financial Content Writer at Univest, covering Indian equity markets with a focus on share price target frameworks, technical analysis education, and sector deep-dives. Her published work spans bull-case/bear-case share price analysis, event-driven stock reactions, and beginner-friendly educational guides. Her articles blend fundamental analysis (analyst consensus targets, P/E, loan book quality, margin dynamics) with technical analysis (moving averages, 200-DMA, support/resistance levels) — giving retail investors a complete framework before any position. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards. Coverage Areas • Share price targets — REC Ltd, Adani Green Energy (bull/bear case frameworks) • Event-driven analysis — Redington (US tariff impact), Star Cement (technical breakdown) • Technical analysis education — Direct Market Access, 200-DMA, indicator interpretation • Thematic listicles — Highest Dividend Paying Stocks, Real Estate Penny Stocks, Intraday Picks • Sector coverage — IT distribution, renewable energy, infrastructure finance, cement, real estate

Leave a Reply Cancel reply